{"entities":{"Q9844":{"pageid":14005,"ns":120,"title":"Item:Q9844","lastrevid":205765,"modified":"2020-05-21T15:46:03Z","type":"item","id":"Q9844","labels":{"en":{"language":"en","value":"Brana I, et al. Br. J. Cancer (2014) cited as Ref 581 in DOI: 10.1038/s41392-020-0110-5"}},"descriptions":{"en":{"language":"en","value":"Cited in: \"Targeting cancer stem cell pathways for cancer therapy\" in Signal Transduct Target Ther; 2020 ; 5 8"}},"aliases":[],"claims":{"P17":[{"mainsnak":{"snaktype":"value","property":"P17","datavalue":{"value":{"entity-type":"item","numeric-id":7916,"id":"Q7916"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9844$D22189C9-CB6B-4E3F-930E-88DFCA24DF0C","rank":"normal"}],"P94":[{"mainsnak":{"snaktype":"value","property":"P94","datavalue":{"value":{"entity-type":"item","numeric-id":8449,"id":"Q8449"},"type":"wikibase-entityid"},"datatype":"wikibase-item"},"type":"statement","id":"Q9844$EAD8350F-A2CA-460E-AC7B-E6698E89AF1A","rank":"normal"}],"P149":[{"mainsnak":{"snaktype":"value","property":"P149","datavalue":{"value":"Brana I","type":"string"},"datatype":"string"},"type":"statement","id":"Q9844$46E77D42-BF16-4555-BFCD-C13F01848819","rank":"normal"}],"P138":[{"mainsnak":{"snaktype":"value","property":"P138","datavalue":{"value":"10.1038/bjc.2014.497","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9844$E3A08187-E0D6-4093-AC54-334DE74EA5AE","rank":"normal"}],"P140":[{"mainsnak":{"snaktype":"value","property":"P140","datavalue":{"value":"25290091","type":"string"},"datatype":"external-id"},"type":"statement","id":"Q9844$FD17BE83-435B-4F0D-A2C1-970933CF50ED","rank":"normal"}],"P100":[{"mainsnak":{"snaktype":"value","property":"P100","datavalue":{"value":{"time":"+2014-01-01T00:00:00Z","timezone":0,"before":0,"after":0,"precision":9,"calendarmodel":"http://www.wikidata.org/entity/Q1985727"},"type":"time"},"datatype":"time"},"type":"statement","id":"Q9844$B7AB1499-CB20-4B8B-BBFC-5000CA7C00B4","rank":"normal"}],"P102":[{"mainsnak":{"snaktype":"value","property":"P102","datavalue":{"value":"Br. J. Cancer","type":"string"},"datatype":"string"},"type":"statement","id":"Q9844$CE27FA04-53B7-47F0-AD83-30F1925CDF23","rank":"normal"}],"P103":[{"mainsnak":{"snaktype":"value","property":"P103","datavalue":{"value":"111","type":"string"},"datatype":"string"},"type":"statement","id":"Q9844$5D1694EC-E668-4AC8-8A6C-CC75D80AF7C1","rank":"normal"}],"P93":[{"mainsnak":{"snaktype":"value","property":"P93","datavalue":{"value":{"text":"A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206 the mTOR inhibitor ridaforolimus or the NOTCH inhibitor MK-0752 in patients with advanced solid tumours","language":"en"},"type":"monolingualtext"},"datatype":"monolingualtext"},"type":"statement","id":"Q9844$A705D73E-F44E-4BC4-BB39-A4EE2D18D2B2","rank":"normal"}],"P105":[{"mainsnak":{"snaktype":"value","property":"P105","datavalue":{"value":"1932-1944","type":"string"},"datatype":"string"},"type":"statement","id":"Q9844$DA7376E0-5560-4939-AD00-5A01E8937BFA","rank":"normal"}]},"sitelinks":{"sliswiki":{"site":"sliswiki","title":"Brana I, et al. Br. J. Cancer (2014) cited as Ref 581 in DOI: 10.1038/s41392-020-0110-5","badges":[],"url":"https://wikibase.slis.ua.edu/wiki/Brana_I,_et_al._Br._J._Cancer_(2014)_cited_as_Ref_581_in_DOI:_10.1038/s41392-020-0110-5"}}}}}